Search results for " Atherosclerosis"

showing 10 items of 159 documents

GLP-1 receptor agonists, carotid atherosclerosis and retinopathy

2017

It is known that diabetes is associated with the development of premature atherosclerosis and microvascular complications and consequently increased cardiovascular (CV) morbidity and mortality. In ...

PharmacologyCarotid atherosclerosismedicine.medical_specialtybusiness.industryglucagon-like peptide 1 receptor agonistscarotid atherosclerosis030209 endocrinology & metabolismGeneral Medicine030204 cardiovascular system & hematologyCardiovascular riskmedicine.disease03 medical and health sciences0302 clinical medicinePremature atherosclerosisDiabetes mellitusInternal medicineretinopathymedicineCardiologyPharmacology (medical)businessGlucagon-like peptide 1 receptorRetinopathyExpert Opinion on Pharmacotherapy
researchProduct

<p>Endothelial Function in Obese Patients Treated with Bariatric Surgery</p>

2020

Purpose Bariatric surgery (BS) is becoming an increasingly frequent treatment option especially in people with morbid obesity, demonstrating that it is able to reduce total mortality and cardiovascular (CV) risk. Despite endothelial dysfunction is an essential requisite contributing to atherosclerosis and predicting CV events, only some studies have investigated the effects of BS on endothelial function with controversial results. In this study, the effects of weight loss on endothelial function were investigated in obese patients after BS and compared with patients after medical nutrition treatment (MNT). Patients and Methods Seventeen obese patients who underwent BS procedures (9 adjustab…

Pharmacologymedicine.medical_specialtybusiness.industry030209 endocrinology & metabolism030204 cardiovascular system & hematologymedicine.diseaseObesitySurgeryTotal mortality03 medical and health sciences0302 clinical medicineWeight lossSubclinical atherosclerosismedicine.arteryInternal MedicinemedicineMedical nutrition therapyEndothelial dysfunctionmedicine.symptomBrachial arterybusinessAfter treatmentDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy
researchProduct

SEVERITY OF CAROTID DISEASE AND RENAL HEMODYNAMICS IN HYPERTENSIVE PATIENTS WITH AND WITHOUT IMPAIRED RENAL FUNCTION

2014

RENAL RESISTIVE INDEXCAROTID ATHEROSCLEROSISRENAL HEMODYNAMICS
researchProduct

RISK FACTORS, VASCULAR AGING AND ATHEROSCLEROSIS: 3rd ANTONIO STRANO LECTURE

2006

RISK FACTORS, VASCULAR AGING AND ATHEROSCLEROSIS: 3rd ANTONIO STRANO LECTURE

RISK FACTORS VASCULAR AGING AND ATHEROSCLEROSIS: 3rd ANTONIO STRANO LECTURE
researchProduct

Response to letter by Drs. Mohammed Abbas, Maria Sessa, and Francesco Corea

2006

RISKbusiness.industryCarotid arteriesINFECTIONCAROTID ATHEROSCLEROSISMedicineGeneral MedicineAnatomybusinessBURDEN
researchProduct

Heat Shock Protein-60 and Risk for Cardiovascular Disease

2011

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. There is growing evidence that molecularchaperones, many of which are heat shock proteins HSPs, are involved in CVD pathogenesis. In this review we focus on HSP60,the human mitochondrial chaperone that also displays extramitochondrial and extracellular functions. HSP60 is typically cytoprotectivebut a number of stress conditions determine its conversion to a potentially toxic molecule for cells and tissues. We present illustrative examplesof specific subtypes of CVD where HSP60 is implicated in the initiation and/or progression of disease. The data not only indicatea pathogenic role for HSP60 but also its …

Riskanimal structuresChaperonin Heat shock protein-60 cardiomyocytes heart failure cardiovascular diseases atherosclerosisChaperonin heat shock protein 60 cardiomyocytes heart failure cardiovascular disease atherosclerosis apoptosis microRNAs (miRs) diabetes Atrial fibrillationApoptosischemical and pharmacologic phenomenaDiseaseBioinformaticsAutoimmune DiseasesPathogenesisHeat shock proteinAtrial FibrillationDrug DiscoveryExtracellularAnimalsHumansMyocytes CardiacHeart FailurePharmacologybiologyfungiChaperonin 60AtherosclerosisResponse to treatmentCardiovascular DiseasesReperfusion InjuryChaperone (protein)HypertensionImmunologybiology.proteinHSP60Stress conditionsBiomarkersCurrent Pharmaceutical Design
researchProduct

Gli aneurismi dell'aorta addominale

2009

Not available

Settore BIO/17 - IstologiaAbdominal aortic aneurism ACE IL MMPs PAF TIMP-2 atherosclerosis EVARSettore MED/22 - Chirurgia VascolareAneurisma aorta addominale ACE IL MMPs PAF EVAR
researchProduct

Role of TLR Polymorphisms in Aging and Age-Related Diseases

2017

Innate immunity provides the first line of host defense against infection by recognizing and killing microbes, and simultaneously activating an instructive immune response. Toll-like receptors (TLRs) are principal mediators of rapid microbial recognition, and they mainly function by detecting exogenous pathogen-associated molecular patterns. Recognition of their ligands actives signaling ways, which culminate in evocating acute host responses, involved in killing pathogens. Here, we describe the involvement of TLR4 polymorphisms in aging, and particularly in immunosenescence and age-related diseases, suggesting the crucial role of molecules of innate immunity in the pathophysiology of these…

Settore MED/04 - Patologia Generalebusiness.industryAge relatedImmunologySettore MED/05 - Patologia ClinicaMedicineTLR4 • Alzheimer’s disease • Prostate cancer • Diabetes • Atherosclerosis • Aneurysm • Longevitybusiness
researchProduct

Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidis…

2020

High levels of LDL cholesterol (LDL-C) represent a causal factor for cardiovascular diseases on an atherosclerotic basis, with a direct correlation between these and mortality or cardiovascular events, such that the reduction of both is associated proportionally and linearly with the reduction of LDL-C.Statins and ezetimibe are used for LDL-C lowering but may not be sufficient to achieve the targets defined by the ESC/EAS guidelines, which recommend use of PCSK9 inhibitors for further LDL-C reduction in patients not at goal.This project submitted 86 clinical scenarios to a group of experts, cardiologists, internists and lipidologists, collecting their opinion on the appropriateness of diffe…

Settore MED/09 - Medicina InternaConsensusPCSK9 inhibitorFamilial hypercholesterolemiaHypercholesterolemiaAntibodies Monoclonal Humanized; Anticholesteremic Agents; Atherosclerosis; Cholesterol LDL; Consensus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Italy; Risk Assessment; Risk Factors; Cardiovascular DiseasesConsensuAntibodies Monoclonal HumanizedRisk AssessmentAntibodiesLDLAcute coronary syndrome; Alirocumab; Cardiovascular risk; Familial hypercholesterolemia; PCSK9 inhibitors; Antibodies Monoclonal Humanized; Anticholesteremic Agents; Atherosclerosis; Cholesterol LDL; Consensus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Italy; Risk Assessment; Risk Factors; Cardiovascular DiseasesRisk FactorsAnticholesteremic AgentMonoclonalHumansHumanizedAnticholesteremic AgentsCholesterol LDLCardiovascular riskAtherosclerosisCholesterolItalyPCSK9 inhibitorsCardiovascular DiseasesAtherosclerosiAcute coronary syndromeHydroxymethylglutaryl-CoA Reductase InhibitorsAlirocumab
researchProduct

Platelet count and MPV as predictive markers of atherosclerosis in familial Mediterranean fever

2017

Familial Mediterranean Fever (FMF) is an auto inflammatory syndrome, characterized by recurrent febrile episodes, arthritis, oral aphthous stomatitis, rash, serositis, abdominal and thoracic pain. Longterm outcome is conventionally linked to the severity of the recurrent attacks and to the risk of systemic amyloidosis. However recent studies highlighted the role of chronic inflammatory diseases in the insurance of atherosclerosis. Risk factors for atherosclerosis are also recently identified in a higher medium platelet volume (MPV).

Settore MED/38 - Pediatria Generale E SpecialisticaFamilial Mediterranean Fever medium platelet volume atherosclerosis
researchProduct